Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene Limited (ASX:IMU) Three Complete Responses in Azer-Cel Phase 1b Trial

(3:51)

Imugene MAST trial delivers two-year complete response in bile tract cancer patient

(4:54)

Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24

(26:56)

Imugene opens enrolment for Bile Tract Cancer expansion study

(5:2)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Imugene Science Series With Dr Yuman Fong - November 2024

(20:20)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Imugene Investor Presentation | Non-deal Roadshow 2023 Australia

(44:28)

A Californian Cancer Killer Professor Yuman Fong and his work with Imugene

(26:16)

Jervois Global (JRV) - Capital Raise Timing \u0026 Amount Explained

(32:44)

Imugene steps up dosage at groundbreaking VAXINIA cancer trial

(19:3)

Investor webinar: Azer-cel trial update, September 2024

(25:35)

Imugene's Founder and Executive Chairman's keynote speech at Emerging Small Caps Summit 2021

(19:6)

Investor Presentation post ASX news: Imugene and Eureka Therapeutics onCARlytics Collaboration

(26:56)

Discussing Imugene's Biotech Pipeline

(9:35)

Imugene has opened enrollment for its expansion study in bile tract cancer patients

(1:5)

Imugene begins VAXINIA trial for bile tract cancer

(10:)

Imugene (ASX:IMU) | JMM \u0026 éthica Capital Innovation Interview \\ May 2024

(5:4)

How Imugene is Turning Viruses into Cancer-Fighting Heroes!

(32:27)

Imugene forges development path of immunotherapies and cancer-killing virus

(24:2)

Just the Facts: Imugene receives Orphan Drug Designation for VAXINIA from FDA

(1:58)

Imugene CEO talks 2024 milestones and oncolytic opportunities

(4:28)

MD \u0026 CEO Leslie Chong Discusses Bile Tract Cancer Study Expansion \u0026 Strategic Partnership

(6:20)

CAR T Explained

(3:58)

Imugene welcomes dosing of first patient in nextHERIZON Phase 2 clinical trial

(5:20)